Should You Hold Intellia Therapeutics Inc (NTLA) in Biotechnology Industry?

A rating of 80 puts Intellia Therapeutics Inc (NTLA) near the top of the Biotechnology industry according to InvestorsObserver. Intellia Therapeutics Inc's score of 80 means it scores higher than 80% of stocks in the industry. Intellia Therapeutics Inc also received an overall rating of 52, putting it above 52% of all stocks. Biotechnology is ranked 93 out of the 148 industries.

NTLA has an Overall Score of 52. Find out what this means to you and get the rest of the rankings on NTLA!

See Full NTLA Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 52 means the stock is more attractive than 52 percent of stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Intellia Therapeutics Inc Stock Today?

Intellia Therapeutics Inc (NTLA) stock is trading at $147.25 as of 10:36 AM on Friday, Sep 17, a drop of -$6.60, or -4.29% from the previous closing price of $153.85. The stock has traded between $147.25 and $156.02 so far today. Volume today is low. So far 199,775 shares have traded compared to average volume of 979,832 shares. Click Here to get the full Stock Report for Intellia Therapeutics Inc stock.